Hungarian study aims to unlock secrets of esophageal cancer survival

NCT ID NCT06713993

Recruiting now Knowledge-focused Sponsor: Semmelweis University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 100 people newly diagnosed with esophageal cancer in Hungary. Researchers will track heart function, nutrition, physical ability, and mental health before and after surgery. The goal is to find which factors are linked to better survival and quality of life, so doctors can improve care. No new drugs or treatments are being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could identify key factors—like nutrition or heart function—that doctors can target to improve outcomes for esophageal cancer patients.
What could go wrong: This is an observational study, not a treatment trial. It can find links but cannot prove what works. Results may not apply to other countries or groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER (ESC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cardiovascular Abnormalities esophageal cancer Esophageal Neoplasms Frailty gastroesophageal junction adenocarcinoma heart failure Malnutrition Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ESOPHAGEAL CANCER (ESC)

Contacts and locations

Locations

Semmelweis University
RECRUITING

Budapest, Hungary

More trials for these conditions

Other studies related to the condition(s) this trial covers.